Pregabalin 75 or 150 mg BID for 7 weeks followed by open label pregabalin 150 mg BID for 4 weeks + Placebo first followed by open label pregabalin
ApprovedTerminated 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Abdominal Pain
Conditions
Abdominal Pain, Surgical Adhesions
Trial Timeline
Mar 1, 2006 → Aug 1, 2008
NCT ID
NCT00310765About Pregabalin 75 or 150 mg BID for 7 weeks followed by open label pregabalin 150 mg BID for 4 weeks + Placebo first followed by open label pregabalin
Pregabalin 75 or 150 mg BID for 7 weeks followed by open label pregabalin 150 mg BID for 4 weeks + Placebo first followed by open label pregabalin is a approved stage product being developed by Pfizer for Abdominal Pain. The current trial status is terminated. This product is registered under clinical trial identifier NCT00310765. Target conditions include Abdominal Pain, Surgical Adhesions.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00310765 | Approved | Terminated |
Competing Products
20 competing products in Abdominal Pain